Key facts
- This page summarizes Stephen L. Miller's Form 4 filing for Medline Inc. (MDLN).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 21 Aug 2026, 16:30.
Stephen L. Miller - 19 Aug 2026 Form 4 Insider Report for Medline Inc. (MDLN)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- MDLN
- Reported as of
- 19 Aug 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 21 Aug 2026, 16:30:03 UTC
- Prior SEC filing
- 17 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Nicole Fritz, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Stephen L. Miller filed Form 4 for Medline Inc. (MDLN) on 21 Aug 2026.
Change
- Previous filing in this sequence was filed on 17 Jun 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002060964
Primary reporting owner
Miller Stephen L
- Relationship
- Chief Operating Officer
- Address
- C/O MEDLINE INC., 3 LAKES DRIVE, NORTHFIELD
- Signature
- /s/ Nicole Fritz, Attorney-in-Fact
- Signature date
- 21 Aug 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MDLN
transaction
Derivative
Incentive Units of Medline Holdings, LP
Award
- Transaction value
- Shares
- +87,667
- Change %
- Price
- Shares after
- 87,667
- Date
- 19 Aug 2026
- Ownership
- See Footnotes
- Underlying class
- Class A Common Stock
- Underlying amount
- 87,667
- Exercise price
- $19.01
- Footnotes
- F1, F2, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Represents performance-based incentive units of Medline Holdings, LP ("Incentive Units"), that were earned as a result of the achievement of certain performance criteria as certified by the compensation committee of the Issuer's board of directors on August 19, 2026. These Incentive Units are fully vested.
Footnote F2
Incentive Units are "profit interests" having economic characteristics similar to stock appreciation rights. Vested Incentive Units are convertible, at the holder's election, into a number of Common Units generally equal to (a) the product of the number of vested Incentive Units to be converted with a given per unit participation threshold and then-current difference between the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Class A Common Stock) and the per unit participation threshold of such vested Incentive Units divided by (b) the per unit value of a Common Unit at the time of the conversion (based on the public trading price of a share of Class A Common Stock), subject to certain adjustments.
Footnote F3
(Continued from Footnote 2 above) Common Units are exchangeable on a one-for-one basis for shares of Class A Common Stock pursuant to the terms of the Exchange Agreement. These Incentive Units have no expiration date. Such Incentive Units are held indirectly through Medline Management Aggregator LLC.
Footnote F4
These securities are held by a trust, of which the Reporting Person is a trustee.